Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes

Chlamydia trachomatis, the most common bacterial sexually transmitted infection worldwide, is responsible for considerable health burden due to its significant sequelae. There are growing concerns about chlamydial treatment and management due to widely documented increasing burden of repeat infectio...

Full description

Bibliographic Details
Main Authors: Wilhelmina M. Huston, Amba Lawrence, Bryan A. Wee, Mark Thomas, Peter Timms, Lenka A. Vodstrcil, Anna McNulty, Ruthy McIvor, Karen Worthington, Basil Donovan, Samuel Phillips, Marcus Y. Chen, Christopher K. Fairley, Jane S. Hocking
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1012835/full
_version_ 1811194664225603584
author Wilhelmina M. Huston
Amba Lawrence
Bryan A. Wee
Mark Thomas
Peter Timms
Lenka A. Vodstrcil
Lenka A. Vodstrcil
Anna McNulty
Ruthy McIvor
Karen Worthington
Basil Donovan
Samuel Phillips
Marcus Y. Chen
Marcus Y. Chen
Christopher K. Fairley
Jane S. Hocking
author_facet Wilhelmina M. Huston
Amba Lawrence
Bryan A. Wee
Mark Thomas
Peter Timms
Lenka A. Vodstrcil
Lenka A. Vodstrcil
Anna McNulty
Ruthy McIvor
Karen Worthington
Basil Donovan
Samuel Phillips
Marcus Y. Chen
Marcus Y. Chen
Christopher K. Fairley
Jane S. Hocking
author_sort Wilhelmina M. Huston
collection DOAJ
description Chlamydia trachomatis, the most common bacterial sexually transmitted infection worldwide, is responsible for considerable health burden due to its significant sequelae. There are growing concerns about chlamydial treatment and management due to widely documented increasing burden of repeat infections. In the current study, a cohort study design of 305 women with urogenital chlamydial infections demonstrated that 11.8% of women experienced repeat infections after treatment with azithromycin. The chlamydial DNA load measured by quantitative PCR was higher in women who experienced a repeat infection (p = 0.0097) and repeat infection was associated with sexual contact. There was no genomic or phenotypic evidence of azithromycin resistance within the chlamydial isolates. During repeat infection, or repeat positive tests during follow up, vaginal chlamydial gene expression (ompA, euo, omcB, htrA, trpAB) was markedly higher compared to baseline, and two of the selected immune genes analyzed had significantly lower expression at the time of repeat infection. Overall, there are two implications of these results. The results could be generalized to all recent infections, or repeat positive events, and indicate that chlamydial infections are have higher transcriptional activity of select genes early in the infection in women. Alternatively, after azithromycin treatment, repeat infections of Chlamydia may be more transcriptionally active at certain genes, and there may be post-treatment immunological alterations that interplay into repeat exposures establishing an active infection. The potential that recent infections may involve a higher level of activity from the organism may have implications for management by more regular testing of the most at risk women to reduce the risk of sequelae.
first_indexed 2024-04-12T00:30:34Z
format Article
id doaj.art-04faf6529dec426982a6acb894439c43
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T00:30:34Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-04faf6529dec426982a6acb894439c432022-12-22T03:55:20ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-10-011010.3389/fpubh.2022.10128351012835Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genesWilhelmina M. Huston0Amba Lawrence1Bryan A. Wee2Mark Thomas3Peter Timms4Lenka A. Vodstrcil5Lenka A. Vodstrcil6Anna McNulty7Ruthy McIvor8Karen Worthington9Basil Donovan10Samuel Phillips11Marcus Y. Chen12Marcus Y. Chen13Christopher K. Fairley14Jane S. Hocking15Faculty of Science, University of Technology Sydney, Ultimo, NSW, AustraliaInstitute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, AustraliaInstitute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, AustraliaFaculty of Science, University of Technology Sydney, Ultimo, NSW, AustraliaBioinnovation Centre, University of the Sunshine Coast, Sippy Downs, QLD, AustraliaMelbourne Sexual Health Centre, Central Clinical School, Monash University, Carlton, VIC, AustraliaCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, AustraliaSydney Sexual Health Centre, Sydney, NSW, AustraliaSydney Sexual Health Centre, Sydney, NSW, AustraliaMelbourne Sexual Health Centre, Alfred Health, Carlton, VIC, AustraliaKirby Institute, University of New South Wales, Kensington, NSW, AustraliaBioinnovation Centre, University of the Sunshine Coast, Sippy Downs, QLD, AustraliaMelbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, Australia0Australia and Melbourne Sexual Health Centre, Carlton, VIC, AustraliaMelbourne Sexual Health Centre, Alfred Health, Carlton, VIC, AustraliaCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, VIC, AustraliaChlamydia trachomatis, the most common bacterial sexually transmitted infection worldwide, is responsible for considerable health burden due to its significant sequelae. There are growing concerns about chlamydial treatment and management due to widely documented increasing burden of repeat infections. In the current study, a cohort study design of 305 women with urogenital chlamydial infections demonstrated that 11.8% of women experienced repeat infections after treatment with azithromycin. The chlamydial DNA load measured by quantitative PCR was higher in women who experienced a repeat infection (p = 0.0097) and repeat infection was associated with sexual contact. There was no genomic or phenotypic evidence of azithromycin resistance within the chlamydial isolates. During repeat infection, or repeat positive tests during follow up, vaginal chlamydial gene expression (ompA, euo, omcB, htrA, trpAB) was markedly higher compared to baseline, and two of the selected immune genes analyzed had significantly lower expression at the time of repeat infection. Overall, there are two implications of these results. The results could be generalized to all recent infections, or repeat positive events, and indicate that chlamydial infections are have higher transcriptional activity of select genes early in the infection in women. Alternatively, after azithromycin treatment, repeat infections of Chlamydia may be more transcriptionally active at certain genes, and there may be post-treatment immunological alterations that interplay into repeat exposures establishing an active infection. The potential that recent infections may involve a higher level of activity from the organism may have implications for management by more regular testing of the most at risk women to reduce the risk of sequelae.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1012835/fullChlamydiasexually transmitted infectionrepeat infectionsgenomicsgene expressionazithromycin
spellingShingle Wilhelmina M. Huston
Amba Lawrence
Bryan A. Wee
Mark Thomas
Peter Timms
Lenka A. Vodstrcil
Lenka A. Vodstrcil
Anna McNulty
Ruthy McIvor
Karen Worthington
Basil Donovan
Samuel Phillips
Marcus Y. Chen
Marcus Y. Chen
Christopher K. Fairley
Jane S. Hocking
Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
Frontiers in Public Health
Chlamydia
sexually transmitted infection
repeat infections
genomics
gene expression
azithromycin
title Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
title_full Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
title_fullStr Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
title_full_unstemmed Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
title_short Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
title_sort repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes
topic Chlamydia
sexually transmitted infection
repeat infections
genomics
gene expression
azithromycin
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1012835/full
work_keys_str_mv AT wilhelminamhuston repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT ambalawrence repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT bryanawee repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT markthomas repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT petertimms repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT lenkaavodstrcil repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT lenkaavodstrcil repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT annamcnulty repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT ruthymcivor repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT karenworthington repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT basildonovan repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT samuelphillips repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT marcusychen repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT marcusychen repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT christopherkfairley repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes
AT janeshocking repeatinfectionswithchlamydiainwomenmaybemoretranscriptionallyactivewithlowerresponsesfromsomeimmunegenes